★★★★★ 5
Love
Color: Gold, Size: 3.38 Fl Oz (Pack of 1)
I love how this smells, looks and feel
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 15, 2026
does my insurance cover glp 1 Medicaid Coverage of and Spending on GLP-1s
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
Retatrutide Peptide in Metabolic Research A Triple GLP 1, GIP and Glucagon Receptor Agonist Gentaur PCR kit, ELISA kit, Antibodies Is Metformin Considered a GLP 1? Key Differences Explained Fella Health Noom Introduces GLP 1 Microdoses of Compounded Ozempic, Wegovy Current Insights, Advantages and Challenges of Small Molecule Glucagon like Peptide 1 Receptor Agonists: A Scoping Review Published in Journal of Brown Hospital Medicine Renoprotective Effects of DPP 4 Inhibitors
Quick Dispatch:
Your does my insurance cover glp 1 Medicaid Coverage of and Spending on GLP-1s orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your does my insurance cover glp 1 Medicaid Coverage of and Spending on GLP-1s ships.
Need Help?
Questions about does my insurance cover glp 1 Medicaid Coverage of and Spending on GLP-1s, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for does my insurance cover glp 1 Medicaid Coverage of and Spending on GLP-1s in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Most insurance plans don’t cover GLP-1s for weight loss. Here is how to check what may be covered in your plan. As always, happy to help with any questions you may have on insurance coverage! ,
24.65
Why payers are hesitant to cover GLP-1 drugs for weight loss
22.25
My Insurance Won't Cover GLP-1 Drugs. What Now?
22.80
GLP-1 Insurance Coverage in Florida: What Florida Blue, UHC, Medicare, Oscar & Other Plans Actually Cover
26.10
Navigating Changes to GLP-1 Medication Coverage
26.08
GLP-1 Coverage in Employer Plans Could Nearly Double in 2024
23.45
2025 GLP-1 Insurance Coverage Checker Report
27.64
4.4 ★★★★★
Based on 660 reviews
Sort
Product Reviews
★★★★★ 3
Glass bottle
Color: Gold, Size: 3.38 Fl Oz (Pack of 1)
Smells nice, not the shimmer I was looking for. It wasn’t super glittery like another brand I had. Also it’s in a glass bottle. So I didn’t feel comfortable packing it on my trip.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 26, 2026
★★★★★ 5
Shimmer body oil
Color: Gold, Size: 3.38 Fl Oz (Pack of 1)
Nice Product
Lite and a little bit of shimmer
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 21, 2026
★★★★★ 5
Probably buy again
Color: Gold, Size: 3.38 Fl Oz (Pack of 1)
It actually moisturizes pretty well, smells pretty amazing and its not greasy. but could make it easier to get the oil out.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 18, 2026
★★★★★ 2
Only a glitter
Color: Gold, Size: 3.38 Fl Oz (Pack of 1)
Not as expected
It doesnt give any tan/ gold color like the other body shimmers
Its only a glitter
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 21, 2026
recommand products
Integrated framework for tirzepatide in HFpEF management. Through
22.30
Tirzepatide Benefits in Obesity-Related HFpEF Are Consistent Across BMI and Enhanced by Weight Loss. - Content
22.21
Therapy for HFpEF: A step forward brings new hope for people with obesity and diabetes: Med
20.66
Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial
20.43
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial
24.35